£1.5M
The pre seed round was led by Episode 1 Ventures and will support infrastructure development and team expansion.
"We are really excited, this investment will help Sable Bio redefine drug safety assessment and change the ways actionable biomedical insights are generated. Working with with leading investors Episode 1 and Seedcamp is enabling us to build an exceptional team and a platform to accelerate safer drug development for patients in need"
